Yearender: Health | After splash in 2025, weight-loss drugs poised to take off this year Despite limited uptake, weight-loss drugs have topped drug sales in India by value marking a shift in how people perceive conditions such as obesity
A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia
Inject SubQ in the abdomen
At NuLevel Wellness Medspa in Prescott Valley, AZ, semaglutide treatment is tailored to each individuals needs
"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Eli Lilly and Company , 11 Dec
This work was funded by the Clinical Research Special Project of Shandong University of Traditional Chinese Medicine (LCKY202429), the Basic Research Projects of Yantai Science and Technology Innovation Development Plan (2023JCYJ062), and the High-level Talent Research Start-up Fund Project of Shandong Xiehe University (SDXHQD2024054)